New Jersey · 2026-2027 Regular Session · Bill

S 4194: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

In committee Last action June 30, 2026: Substituted by A4852 (ACS)

Plain-language summary

S 4194 is a bill introduced in the New Jersey Senate on May 11, 2026. According to its official title, it concerns: Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*. Primary sponsor: Joe Vitale (Democratic), Vin Gopal (Democratic), Raj Mukherji (Democratic). Most recent recorded action (June 30, 2026): Substituted by A4852 (ACS).

Sponsors

Primary sponsors: Joe Vitale (Democratic); Vin Gopal (Democratic); Raj Mukherji (Democratic).